FDA approves Incyte's Opzelura cream for children aged two and older with atopic dermatitis, expanding its use beyond teens ...

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis ...

Incyte INCY announced that the FDA has approved the label expansion of Opzelura (ruxolitinib) cream 1.5%. Opzelura, a topical ...

The most effective treatments for eczema accomplish three things: They calm inflammation, bring relief from itch and restore ...

The US FDA has approved ruxolitinib (Opzelura) cream 1.5% for the short-term and noncontinuous chronic treatment of ...

There is no known cure for psoriasis, but over-the-counter (OTC) and prescription-strength creams can relieve symptoms. The best options include steroid creams, scale softeners, anti-itch solutions, ...

Eczema, or atopic dermatitis, often worsens during seasonal changes like monsoon and autumn. Fluctuating humidity, allergens, and infections can trigger flare-ups.

Eczema typically refers to a skin condition that causes constant itching, redness, and dryness. For some people dealing with eczema, it can be an uphill fight. As much as there are numerous ...

Dermatologist highlights cosmeceutical products useful in the management of acne, atopic dermatitis, and melasma.

July 24, 2025 – The FDA has approved a new treatment as the first and only skin cream for a specific type of hand eczema that affects about 1 in every 10 people globally. The cream, sold under the ...

ZORYVE Allure Best of Beauty Product Image Allure Best of Beauty Breakthrough Award Winner ZORYVE (roflumilast) cream 0.15%; ...

Adults who suffer from the common disorder are significantly more likely to express suicidal thoughts, concerning new ...